时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
研究问题
Through molecular biology techniques and AD cellular models, we aimed to elucidate: (1) the regulatory effect of miR-615-3p overexpression or inhibition on neuronal mitophagy; (2) whether miR-615-3p negatively regulates SESN2 expression to…；However, its underlying molecular mechanisms remain to be further elucidated.
方法
Data were analyzed using FlowJo software (Becton, Dickinson and Company). 2.3 Immunofluorescence (ICC) staining HT22 cells were fixed with 4% paraformaldehyde for 15 min, permeabilized with 0.1% Triton X-100, and blocked with 5% bovine…；The cells were then incubated overnight at 4 °C with an anti-SESN2 primary antibody (Proteintech, 10795-1-AP), followed by incubation with a FITC-conjugated secondary antibody for 1 h at room temperature.；The Dual-Luciferase ® Reporter kit was used to measure luciferase activity. 2.11 Statistical analysis Data, expressed as means ± standard error, were repeated ≥ three times independently and analyzed using GraphPad Prism software (version…
核心结论
Consistently, immunofluorescence staining showed that the SESN2 signal was significantly increased in the SESN2-OE group and markedly decreased in the SESN2-KD group compared with the corresponding NC groups ( p < 0.01 or p < 0.001, ).；Next, it was observed that the relative SESN2 mRNA and protein expressions were significantly decreased in the model group, and the overexpression of miR-615-3p would downregulate the SESN2 levels ( , ).；The ELISA analysis in showed that the increased levels of IL-1β and IL-18 in model cells were significantly enhanced by SESN2 knockout but significantly suppressed by overexpressing SESN2 (all p < 0.01).；In the control and model groups, BafA1 treatment significantly further increased LC3-II and p62 levels, whereas in the miR-615-3p-OE group, BafA1 failed to further accumulate LC3-II and p62 (all p > 0.05, ).
局限
These findings support the potential of the SESN2-AMPK axis as a therapeutic target for AD. 4.4 Research limitations and future prospects Some limitations exist in this study.；Further in vivo studies are warranted to validate these observations and explore the translational implications of this regulatory network in AD treatment.
对本项目的价值
参考性证据：线粒体是衰老干预的共同下游效应器，可用于跨器官效应的统一读数。 ｜ 价值分 2.7/5（★★★☆☆）
全文来源
PubMed PMC JATS 全文（正文 29,724 字符，已过 DOI 逐字 + 题名指纹双重归属校验）
原文题录
- 英文标题：miR-615-3p targets SESN2 to inhibit neuronal mitophagy in an in vitro Alzheimer's disease model by regulating the AMPK/ULK1 axis.
- 期刊与标识：Frontiers in molecular neuroscience · PMID 42964017 · DOI 10.3389/fnmol.2026.1873619
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写，依据已获取的期刊全文（方法、样本量与结论已回到原文核对）；未能获取全文的同批条目另行标注「摘要级」，全程未做任何数值推算补全。